An investigation for investors in Affymax, Inc. (NASDAQ:AFFY) shares over potential securities laws violations by …
Shareholders were worried about its cancer-drug pipeline. And the stock was trading at less than $2 a share. In fact, OXiGENE shares had been one of the biotech sector's worst performers in 2010, and the company had to endure the …
Other firms Venus Biosciences Private Limited, Baddi, Everest Formulations, Solan, Arion Healthcare Baddi, Venus Remedies Limited, Jharmajri, Affy Pharma, Baddi, Lifecare Neuro Products Ltd, Baddi, also figured in this list.